Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1982 Mar;136(3):227–235.

Advances in interferon research - Medical Staff Conference.

A A Creasey, T C Merigan
PMCID: PMC1273650  PMID: 6178224

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvin A. M., Feldman S., Merigan T. C. Human leukocyte interferon in the treatment of varicella in children with cancer: a preliminary controlled trial. Antimicrob Agents Chemother. 1978 Apr;13(4):605–607. doi: 10.1128/aac.13.4.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arvin A. M., Yeager A. S., Merigan T. C. Effect of leukocyte interferon on urinary excretion of cytomegalovirus by infants. J Infect Dis. 1976 Jun;133 (Suppl):A205–A210. doi: 10.1093/infdis/133.supplement_2.a205. [DOI] [PubMed] [Google Scholar]
  3. Balkwill F. R., Oliver R. T. Growth inhibitory effects of interferon on normal and malignant human haemopoietic cells. Int J Cancer. 1977 Oct 15;20(4):500–505. doi: 10.1002/ijc.2910200405. [DOI] [PubMed] [Google Scholar]
  4. Besancon F., Ankel H., Basu S. Specificity and reversibility of interferon ganglioside interaction. Nature. 1976 Feb 19;259(5544):576–578. doi: 10.1038/259576a0. [DOI] [PubMed] [Google Scholar]
  5. Brodeur B. R., Merigan T. C. Mechanism of the suppressive effect of interferon on antibody synthesis in vivo. J Immunol. 1975 Apr;114(4):1323–1328. [PubMed] [Google Scholar]
  6. Brouty-Boyé D., Tovey M. G. Inhibition by interferon of thymidine uptake in chemostat cultures of L1210 cells. Intervirology. 1978;9(4):243–252. doi: 10.1159/000148942. [DOI] [PubMed] [Google Scholar]
  7. Chang E. H., Mims S. J., Triche T. J., Friedman R. M. Interferon inhibits mouse leukaemia virus release: an electron microscope study. J Gen Virol. 1977 Feb;34(2):363–367. doi: 10.1099/0022-1317-34-2-363. [DOI] [PubMed] [Google Scholar]
  8. Creasey A. A., Bartholomew J. C., Merigan T. C. Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1471–1475. doi: 10.1073/pnas.77.3.1471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. De Maeyer-Guignard J., Cachard A., De Maeyer E. Delayed-type hypersensitivity to sheep red blood cells: inhibition of sensitization by interferon. Science. 1975 Nov 7;190(4214):574–576. doi: 10.1126/science.1188355. [DOI] [PubMed] [Google Scholar]
  10. De Maeyer-Guignard J., De Maeyer E., Tovey M. G., Gresser I. Electrophoretically pure mouse interferon exerts multiple biological effects. Ann N Y Acad Sci. 1980;350:347–353. doi: 10.1111/j.1749-6632.1980.tb20634.x. [DOI] [PubMed] [Google Scholar]
  11. De Maeyer E., De Maeyer-Guignard J., Vandeputte M. Inhibition by interferon of delayed-type hypersensitivity in the mouse. Proc Natl Acad Sci U S A. 1975 May;72(5):1753–1757. doi: 10.1073/pnas.72.5.1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Farrell P. J., Sen G. C., Dubois M. F., Ratner L., Slattery E., Lengyel P. Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc Natl Acad Sci U S A. 1978 Dec;75(12):5893–5897. doi: 10.1073/pnas.75.12.5893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Frayssinet C., Gresser I., Tovey M., Lindahl P. Letter: Inhibitory effect of potent interferon preparations on the regeneration of mouse liver after partial hepatectomy. Nature. 1973 Sep 21;245(5421):146–147. doi: 10.1038/245146b0. [DOI] [PubMed] [Google Scholar]
  14. GRESSER I. Metamorphosis of human amnion cells induced by preparations of interferon. Proc Natl Acad Sci U S A. 1961 Nov 15;47:1817–1822. doi: 10.1073/pnas.47.11.1817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gisler R. H., Lindahl P., Gresser I. Effects of interferon on antibody synthesis in vitro. J Immunol. 1974 Aug;113(2):438–444. [PubMed] [Google Scholar]
  16. Gisler R. H., Lindahl P., Gresser I. Effects of interferon on antibody synthesis in vitro. J Immunol. 1974 Aug;113(2):438–444. [PubMed] [Google Scholar]
  17. Goeddel D. V., Yelverton E., Ullrich A., Heyneker H. L., Miozzari G., Holmes W., Seeburg P. H., Dull T., May L., Stebbing N. Human leukocyte interferon produced by E. coli is biologically active. Nature. 1980 Oct 2;287(5781):411–416. doi: 10.1038/287411a0. [DOI] [PubMed] [Google Scholar]
  18. Greenberg H. B., Pollard R. B., Lutwick L. I., Gregory P. B., Robinson W. S., Merigan T. C. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976 Sep 2;295(10):517–522. doi: 10.1056/NEJM197609022951001. [DOI] [PubMed] [Google Scholar]
  19. Gresser I., Maury C., Tovey M. Interferon and murine leukemia. VII. Therapeutic effect of interferon preparations after diagnosis of lymphoma in AKR mice. Int J Cancer. 1976 May 15;17(5):647–651. doi: 10.1002/ijc.2910170514. [DOI] [PubMed] [Google Scholar]
  20. Gresser I., Maury C., Tovey M., Morel-Maroger L., Pontillon F. Progressive glomerulonephritis in mice treated with interferon preparations at birth. Nature. 1976 Sep 30;263(5576):420–422. doi: 10.1038/263420a0. [DOI] [PubMed] [Google Scholar]
  21. Gresser I. On the varied biologic effects of interferon. Cell Immunol. 1977 Dec;34(2):406–415. doi: 10.1016/0008-8749(77)90262-3. [DOI] [PubMed] [Google Scholar]
  22. Gresser I., Tovey M. G., Bandu M. E., Maury C., Brouty-Boyé D. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med. 1976 Nov 2;144(5):1305–1315. doi: 10.1084/jem.144.5.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gresser I., Tovey M. G., Maury C., Bandu M. T. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J Exp Med. 1976 Nov 2;144(5):1316–1323. doi: 10.1084/jem.144.5.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gresser I., Tovey M. G., Maury C., Chouroulinkov I. Lethality of interferon preparations for newborn mice. Nature. 1975 Nov 6;258(5530):76–78. doi: 10.1038/258076a0. [DOI] [PubMed] [Google Scholar]
  25. Grunstein M., Hogness D. S. Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3961–3965. doi: 10.1073/pnas.72.10.3961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Gutterman J. U., Blumenschein G. R., Alexanian R., Yap H. Y., Buzdar A. U., Cabanillas F., Hortobagyi G. N., Hersh E. M., Rasmussen S. L., Harmon M. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med. 1980 Sep;93(3):399–406. doi: 10.7326/0003-4819-93-3-399. [DOI] [PubMed] [Google Scholar]
  27. Havell E. A., Berman B., Ogburn C. A., Berg K., Paucker K., Vilcek J. Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2185–2187. doi: 10.1073/pnas.72.6.2185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hirsch M. S., Ellis D. A., Black P. H., Monaco A. P., Wood M. L. Immunosuppressive effects of an interferon preparation in vivo. Transplantation. 1974 Feb;17(2):234–236. doi: 10.1097/00007890-197402000-00014. [DOI] [PubMed] [Google Scholar]
  29. Huet C., Gresser I., Bandu M. T., Lindahl P. Increased binding of concanavalin A to interferon-treated murine leukemia L 1210 cells. Proc Soc Exp Biol Med. 1974 Oct;147(1):52–57. doi: 10.3181/00379727-147-38279. [DOI] [PubMed] [Google Scholar]
  30. Ida S., Hooks J. J., Siraganian R. P., Notkins A. L. Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med. 1977 Apr 1;145(4):892–906. doi: 10.1084/jem.145.4.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Imanishi J. Inhibition of macrophage migration by virus-induced interferon preparations. Jpn J Microbiol. 1975 Oct;19(5):337–342. doi: 10.1111/j.1348-0421.1975.tb00889.x. [DOI] [PubMed] [Google Scholar]
  32. Killander D., Lindahl P., Lundin L., Leary P., Gresser I. Relationship between the enhanced expression of histocompatibility antigens on interferon-treated L 1210 cells and their position in the cell cycle. Eur J Immunol. 1976 Jan;6(1):56–59. doi: 10.1002/eji.1830060112. [DOI] [PubMed] [Google Scholar]
  33. Knight E., Jr, Hunkapiller M. W., Korant B. D., Hardy R. W., Hood L. E. Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. Science. 1980 Feb 1;207(4430):525–526. doi: 10.1126/science.7352259. [DOI] [PubMed] [Google Scholar]
  34. Knight E., Jr, Korant B. D. A cell surface alteration in mouse L cells induced by interferon. Biochem Biophys Res Commun. 1977 Jan 24;74(2):707–713. doi: 10.1016/0006-291x(77)90360-6. [DOI] [PubMed] [Google Scholar]
  35. Lindahl P., Gresser I., Leary P., Tovey M. Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1284–1287. doi: 10.1073/pnas.73.4.1284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lindahl P., Leary P., Gresser I. Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells. Proc Natl Acad Sci U S A. 1973 Oct;70(10):2785–2788. doi: 10.1073/pnas.70.10.2785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Lindahl P., Leary P., Gresser I. Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci U S A. 1972 Mar;69(3):721–725. doi: 10.1073/pnas.69.3.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Louie A. C., Gallagher J. G., Sikora K., Levy R., Rosenberg S. A., Merigan T. C. Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. Blood. 1981 Oct;58(4):712–718. [PubMed] [Google Scholar]
  39. Lundgren E., Larsson I., Miörner H., Strannegård O. Effects of leukocyte and fibroblast interferon on events in the fibroblast cell cycle. J Gen Virol. 1979 Mar;42(3):589–595. doi: 10.1099/0022-1317-42-3-589. [DOI] [PubMed] [Google Scholar]
  40. Merigan T. C., Gallagher J. G., Pollard R. B., Arvin A. M. Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer. Antimicrob Agents Chemother. 1981 Jan;19(1):193–195. doi: 10.1128/aac.19.1.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Merigan T. C., Rand K. H., Pollard R. B., Abdallah P. S., Jordan G. W., Fried R. P. Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med. 1978 May 4;298(18):981–987. doi: 10.1056/NEJM197805042981801. [DOI] [PubMed] [Google Scholar]
  42. Merigan T. C., Sikora K., Breeden J. H., Levy R., Rosenberg S. A. Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. N Engl J Med. 1978 Dec 28;299(26):1449–1453. doi: 10.1056/NEJM197812282992608. [DOI] [PubMed] [Google Scholar]
  43. Moehring T. J., Moehring J. M., Stinebring W. R. Response of interferon-treated cells to diphtheria toxin. Infect Immun. 1971 Dec;4(6):747–752. doi: 10.1128/iai.4.6.747-752.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Nagata S., Mantei N., Weissmann C. The structure of one of the eight or more distinct chromosomal genes for human interferon-alpha. Nature. 1980 Oct 2;287(5781):401–408. doi: 10.1038/287401a0. [DOI] [PubMed] [Google Scholar]
  45. Nebert D. W., Friedman R. M. Stimulation of aryl hydrocarbon hydroxylase induction in cell cultures by interferon. J Virol. 1973 Feb;11(2):193–197. doi: 10.1128/jvi.11.2.193-197.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Nilsen T. W., Baglioni C. Mechanism for discrimination between viral and host mRNA in interferon-treated cells. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2600–2604. doi: 10.1073/pnas.76.6.2600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Oxman M. N., Levin M. J. Interferon and transcription of early virus-specific RNA in cells infected with simian virus 40. Proc Natl Acad Sci U S A. 1971 Feb;68(2):299–302. doi: 10.1073/pnas.68.2.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. PAUCKER K., CANTELL K., HENLE W. Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells. Virology. 1962 Jun;17:324–334. doi: 10.1016/0042-6822(62)90123-x. [DOI] [PubMed] [Google Scholar]
  49. Pitha P. M., Vengris V. E., Reynolds F. H., Jr The role of cell membrane in the antiviral effect of interferon. J Supramol Struct. 1976;4(4):467–473. doi: 10.1002/jss.400040405. [DOI] [PubMed] [Google Scholar]
  50. Revel M., Bash D., Ruddle F. H. Antibodies to a cell-surface component coded by human chromosome 21 inhibit action of interferon. Nature. 1976 Mar 11;260(5547):139–141. doi: 10.1038/260139a0. [DOI] [PubMed] [Google Scholar]
  51. Revel M., Kimchi A., Shulman L., Fradin A., Shuster R., Yakobson E., Chernajovsky Y., Schmidt A., Shure A., Bendori R. Role of interferon-induced enzymes in the antiviral and antimitogenic effects of interferon. Ann N Y Acad Sci. 1980;350:459–472. doi: 10.1111/j.1749-6632.1980.tb20649.x. [DOI] [PubMed] [Google Scholar]
  52. Rossi G. B., Dolei A., Capobianchi M. R., Peschle C., Affabris E. Interactions of interferon with in vitro model systems involved in hematopoietic cell differentiation. Ann N Y Acad Sci. 1980;350:279–293. doi: 10.1111/j.1749-6632.1980.tb20628.x. [DOI] [PubMed] [Google Scholar]
  53. Scullard G. H., Andres L. L., Greenberg H. B., Smith J. L., Sawhney V. K., Neal E. A., Mahal A. S., Popper H., Merigan T. C., Robinson W. S. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside. Hepatology. 1981 May-Jun;1(3):228–232. doi: 10.1002/hep.1840010306. [DOI] [PubMed] [Google Scholar]
  54. Scullard G. H., Pollard R. B., Smith J. L., Sacks S. L., Gregory P. B., Robinson W. S., Merigan T. C. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis. 1981 Jun;143(6):772–783. doi: 10.1093/infdis/143.6.772. [DOI] [PubMed] [Google Scholar]
  55. Sonnenfeld G., Mandel A. D., Merigan T. C. Time and dosage dependence of immunoenhancement by murine type II interferon preparations. Cell Immunol. 1978 Oct;40(2):285–293. doi: 10.1016/0008-8749(78)90336-2. [DOI] [PubMed] [Google Scholar]
  56. Sonnenfeld G., Meruelo D., McDevitt H. O., Merigan T. C. Effect of type I and type II interferons on murine thymocyte surface antigen expression: induction or selection? Cell Immunol. 1981 Jan 15;57(2):427–439. doi: 10.1016/0008-8749(81)90101-5. [DOI] [PubMed] [Google Scholar]
  57. Strander H., Einhorn S. Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture. Int J Cancer. 1977 Apr 15;19(4):468–473. doi: 10.1002/ijc.2910190406. [DOI] [PubMed] [Google Scholar]
  58. Taniguchi T., Mantei N., Schwarzstein M., Nagata S., Muramatsu M., Weissmann C. Human leukocyte and fibroblast interferons are structurally related. Nature. 1980 Jun 19;285(5766):547–549. doi: 10.1038/285547a0. [DOI] [PubMed] [Google Scholar]
  59. Welsh R. M., Jr Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med. 1978 Jul 1;148(1):163–181. doi: 10.1084/jem.148.1.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Yamamoto K., Yamaguchi N., Oda K. Mechanism of interferon-induced inhibition of early simian virus 40(SV40) functions. Virology. 1975 Nov;68(1):58–70. doi: 10.1016/0042-6822(75)90147-6. [DOI] [PubMed] [Google Scholar]
  61. Zoon K. C., Smith M. E., Bridgen P. J., Anfinsen C. B., Hunkapiller M. W., Hood L. E. Amino terminal sequence of the major component of human lymphoblastoid interferon. Science. 1980 Feb 1;207(4430):527–528. doi: 10.1126/science.7352260. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES